Polysomnography
15
1
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Multimodal Deep Learning Model for Predicting the Apnea-Hypopnea Index in Obstructive Sleep
19/5000 (SYNAPSOT21) Predictive Factors of Sleep Apnea Syndrome in Down Syndrome
Changes in Polysomnography and Rhinomanometry Parameters After Rapid Maxillary Expansion or Adenotonsilectomy in Children With Obstructive Sleep Apnea
Ambulatory Polysomnography in Neurodiverse Children: Feasibility, Quality, and Satisfaction
Screening Moderate to Severe Obstructive Sleep Apnea With Wearable Device
Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children
Alpha-s1 Casein Hydrolysate on Sleep
Validation of Various Sleep Assessment Tools in SICU
Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea
Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database
Home Respiratory Polygraphy in Childhood Sleep Apnea-Hypopnea Syndrome (CHILDSLEEP).
A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)
Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study
Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study
ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients